ICU Medical, Inc.

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroCla…

Medical - Instruments & Supplies

US, San Clemente [HQ]

Financials

Analysts

Wall Street · Earnings · Institutional Sentiment

A comprehensive analysis section that covers unveiling insights about ICU Medical, Inc.'s gradings, price targets and earnings estimates.

Earnings

See the historical earnings and what wall street analysts forecasted and
forecast for future earnings.

Reported

Past Estimate Consensus

Future Estimate Consensus

EPS Revenue EBITDA EBIT SGA

All monetary values are presented in USD ($). E stands for Estimate.
FY	EPS		Revenue [mil.]		Profit [mil.]		EBITDA [mil.]		EBIT [mil.]		Expenses · SGA [mil.]
		E		E		E		E		E		E
2014	2.7500	1.310	313	250	40	19	71	44	51	29	90	67
2015	1.7200	3.778	309	337	26	35	68	71	44	55	88	69
2016	2.8400	4.842	341	378	44	116	113	42	81	8	83	90
2017	3.9000	4.603	379	1,251	63	110	132	140	99	29	89	299
2018	3.5000	8.573	1,292	1,316	68	16	68	67	70	10	303	244
2019	1.3300	7.857	1,400	1,187	28	91	190	183	189	98	328	250
2020	4.9000	6.793	1,266	1,202	101	64	148	144	140	74	276	213
2021	4.1600	7.210	1,271	1,263	86	92	136	191	135	110	283	271
2022	4.8600	6.503	1,316	2,239	103	7	142	218	141	24	302	498
2023	-3.1100	6.390	2,279	2,200	-74	-70	226	256	-3	44	608	550
2024	-1.2300	5.240	2,258	2,309	-29	126	290	258	39	54	584	553
2025	-	6.876	-	2,407	-	165	-	269	-	57	-	576
2026	-	8.375	-	2,485	-	1.F12X/td>	-	1.F121/td>	-	1.F121	-	1.F121
2027	-	8.900	-	2,578	-	0.F13X/td>	-	0.F131/td>	-	0.F131	-	0.F131

Institutional Sentiment

Wall Street · Earnings · Institutional Sentiment

The institutional sentiment measures the direction of new stock gradings
and price targets while comparing them Year-over-Year. We've limited the grading institutes to those we see as top-tier and update this data every month.

Morgan Stanley

1Y Ago:

n/a

Prev. Grade

n/a

Latest

n/a

JP Morgan Chase

1Y Ago:

n/a

Prev. Grade

n/a

Latest

n/a

Citigroup

1Y Ago:

n/a

Prev. Grade

n/a

Latest

n/a

Overall Consensus

Here we aggregate the price targets and gradings of all IBs/AMCs/Brokerage firms inside our database to draw a bigger picture.

Grading Consensus

Click to each, to see the grade

Price Target Consensus

-12.486% $19.58 · MISS

Nov. 6, 2024

Price Then

$173.39

Price Target

$176.40

Price Now

$156.82